CTI BioPharma Corp (CTIC)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Adam R. Craig
Employees:
120
3101 WESTERN AVENUE, SUITE 800, SEATTLE, WA 98121
2062827100

CTI BioPharma Corp. focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis.

Data derived from most recent annual or quarterly report
Market Cap 622.201 Million Shares Outstanding108.967 Million Avg 30-day Volume 4.54 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.15
Price to Revenue44.3051 Debt to Equity-9.0372 EBITDA-111.761 Million
Price to Book Value0.0 Operating Margin-770.9177000000001 Enterprise Value599.71 Million
Current Ratio3.604 EPS Growth-0.557 Quick Ratio3.492
1 Yr BETA 0.8946 52-week High/Low 7.8 / 1.43 Profit Margin-826.012
Operating Cash Flow Growth-78.0928 Altman Z-Score-25.0557 Free Cash Flow to Firm -33.561 Million
View SEC Filings from CTIC instead.

View recent insider trading info

CTI BioPharma Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CTIC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTIC

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-08-11 by LAMPERT MARK N
  • 4: filed on 2022-07-11 by METZGER MICHAEL A
  • 4: filed on 2022-07-07 by METZGER MICHAEL A
  • 4: filed on 2022-07-06 by CRAIG ADAM R
  • 4: filed on 2022-06-17 by KIRSKE DAVID
  • 4: filed on 2022-06-16 by KIRSKE DAVID
  • 4/A: filed on 2022-06-03 by CRAIG ADAM R
  • 4: filed on 2022-06-03 by CRAIG ADAM R
  • 4: filed on 2022-03-11 by TUCKSON REED VAUGHN
  • 4: filed on 2022-03-11 by PERRY MATTHEW D

    • Events (8k)

  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-06-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    8.8 Million total shares from 20 transactions

    Exercise Derivative Conversion (M)

    233.7 Thousand total shares from 7 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BVF I GP LLC

    BIOTECHNOLOGY VALUE FUND II LP

    BVF II GP LLC

    BIOTECHNOLOGY VALUE TRADING FUND OS LP

    BVF PARTNERS OS LTD.

    BVF GP HOLDINGS LLC

    BVF INC/IL

    LAMPERT MARK N

    • Director
    • 10% Owner
    • SEE REMARKSSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    		 2,665,438 2022-08-09 2

    METZGER MICHAEL A

    • Director
    		 0 2022-07-07 3

    CRAIG ADAM R PRESIDENT AND CEO

    • Officer
    • Director
    		 3,598,691 2022-06-30 4

    KIRSKE DAVID EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 497,397 2022-06-17 2

    FISCHER LAURENT

    • Director
    		 80,000 2022-03-09 1

    PARKINSON DAVID ROSS

    • Director
    		 80,000 2022-03-09 1

    PERRY MATTHEW D

    • Director
    		 80,000 2022-03-09 1

    TUCKSON REED VAUGHN

    • Director
    		 80,000 2022-03-09 1

    PARKS DIANE L.

    • Director
    		 80,000 2022-03-09 2

    FONG JAMES K SEE REMARKS

    • Officer
    		 3,565 2022-02-28 1

    JONES DAVID ANDREW EXECUTIVE VICE PRESIDENT

    • Officer
    		 18,553 2021-12-31 1

    SEELEY BRUCE J. EVP, CHIEF OPERATING OFFICER

    • Officer
    		 323,905 2021-06-30 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    • 10% Owner
    		 7,520,600 2021-01-07 0

    BVF GP HOLDINGS LLC

    BVF I GP LLC

    BVF II GP LLC

    • 10% Owner
    • SEE EXPLANATION OF RESPONSES
    		 5,150,400 2020-03-02 0

    TELLING FRED

    • Director
    		 0 2018-09-18 0

    SINGER JACK W EVP, CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2018-05-16 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BIOTECHNOLOGY VALUE TRADING FUND OS LP

    BVF PARTNERS OS LTD.

    BVF INC/IL

    LAMPERT MARK N

    • 10% Owner
    • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    		1,782,594 2018-02-08 2

    LOVE RICHARD L

    • Director
    		 73,718 2017-09-28 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    ISALY SAMUEL D

    • 10% Owner
    		 5,000,000 2017-06-13 0

    NUDELMAN PHILLIP M PHD

    • Director
    		 73,129 2017-04-29 0

    PLUNKETT MATTHEW EVP, CHIEF BUSINESS OFFICER

    • Officer
    • Director
    		 0 2017-03-01 0

    BIANCO JAMES A

    • Director
    		 0 2016-10-02 0

    MUNDINGER MARY ONEIL

    • Director
    		 360,019 2016-04-29 0

    BIANCO LOUIS A EVP, FINANCE & ADMINISTRATION

    • Officer
    		 622,970 2016-03-21 0

    BAUER JOHN H

    • Director
    		 0 2015-09-23 0

    IGNAGNI KAREN

    • Director
    		 0 2015-09-23 0

    BAXTER HEALTHCARE SA

    • 10% Owner
    		 No longer subject to file 2015-04-30 0

    GREGORIAN VARTAN

    • Director
    		 468,937 2014-03-28 0

    BAXTER HEALTHCARE SA

    BAXTER INTERNATIONAL INC

    • 10% Owner
    		 15,673,981 2013-11-25 0

    BENNER STEVEN E EVP, CHIEF MEDICAL OFFICER

    • Officer
    		 396,705 2013-03-21 0

    PHILIPS CRAIG

    • FORMER PRESIDENT
    		 414 2012-11-19 0

    ERAMIAN DANIEL G EVP, CORPORATE COMMUNICATIONS

    • Officer
    		 354,350 2012-09-20 0

    STROMATT SCOTT EVP,CLINICAL DEV & REG AFFAIR

    • Officer
    		 No longer subject to file 2008-04-04 0

    BROWN JADE EVP, CHIEF BUSINESS OFFICER

    • Officer
    		 77,496 2006-06-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS see footnote

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES see footnote

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    		2022-08-11 17:52:51 -0400 2022-08-09 C 2,280 d 0 indirect

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 S 3,850,803 $6.12 d 235,130 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 C 3,754,000 a 3,989,130 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 S 2,890,723 $6.12 d 168,573 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 C 2,426,666 a 2,595,239 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 S 469,040 $6.12 d 19,839 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 C 682,666 a 702,505 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS see footnote

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES see footnote

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    		2022-08-11 17:52:51 -0400 2022-08-09 S 1,289,434 $6.12 d 6,148 indirect

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS see footnote

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES see footnote

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES see footnote

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES see footnote

    		2022-08-11 17:52:51 -0400 2022-08-09 C 1,519,999 a 1,526,147 indirect

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 C 5,631 d 0 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 C 3,640 d 0 direct

    BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

    BIOTECHNOLOGY VALUE FUND L P - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF I GP LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE FUND II LP - Director SEE EXPLANATION OF RESPONSES

    BVF II GP LLC - Director SEE EXPLANATION OF RESPONSES

    BIOTECHNOLOGY VALUE TRADING FUND OS LP - Director SEE EXPLANATION OF RESPONSES

    BVF PARTNERS OS LTD. - Director SEE EXPLANATION OF RESPONSES

    BVF GP HOLDINGS LLC - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    BVF INC/IL - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    LAMPERT MARK N - Director - > 10% Owner SEE EXPLANATION OF RESPONSES

    		2022-08-11 17:52:51 -0400 2022-08-09 C 1,024 d 0 direct

    METZGER MICHAEL A - Director

    		2022-07-11 16:51:10 -0400 2022-07-07 S 1,100 $6.55 d 0 direct yes -1.8237 -1.9757 0.0 1 -5.0152 5

    METZGER MICHAEL A - Director

    		2022-07-11 16:51:10 -0400 2022-07-07 S 400 $6.54 d 1,100 direct yes -1.8237 -1.9757 0.0 1 -5.0152 5

    METZGER MICHAEL A - Director

    		2022-07-11 16:51:10 -0400 2022-07-07 S 400 $6.53 d 1,500 direct yes -1.8237 -1.9757 0.0 1 -5.0152 5

    METZGER MICHAEL A - Director

    		2022-07-11 16:51:10 -0400 2022-07-07 S 3,321 $6.52 d 1,900 direct yes -1.8237 -1.9757 0.0 1 -5.0152 5

    METZGER MICHAEL A - Director

    		2022-07-11 16:51:10 -0400 2022-07-07 S 5,900 $6.51 d 5,221 direct yes -1.8237 -1.9757 0.0 1 -5.0152 5

    METZGER MICHAEL A - Director

    		2022-07-11 16:51:10 -0400 2022-07-07 S 9,000 $6.50 d 11,121 direct yes -1.8237 -1.9757 0.0 1 -5.0152 5

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-06 M 18,223 $0.84 a 41,084 direct -1.2676 -10.9859 0.0 1 -10.9859 6

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-06 S 18,223 $6.11 d 22,861 direct yes -1.2676 -10.9859 0.0 1 -10.9859 6

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-06 M 18,223 d 1,155,554 direct

    METZGER MICHAEL A - Director

    		2022-07-07 17:02:20 -0400 2022-07-05 S 51,963 $6.05 d 50,958 direct yes -6.1341 -6.2767 0.0 1 -9.8431 5

    METZGER MICHAEL A - Director

    		2022-07-07 17:02:20 -0400 2022-07-05 M 91,500 d 28,500 direct

    METZGER MICHAEL A - Director

    		2022-07-07 17:02:20 -0400 2022-07-05 S 27,506 $6.14 d 23,452 direct yes -6.1341 -6.2767 0.0 1 -9.8431 5

    METZGER MICHAEL A - Director

    		2022-07-07 17:02:20 -0400 2022-07-05 S 3,331 $6.23 d 20,121 direct yes -6.1341 -6.2767 0.0 1 -9.8431 5

    METZGER MICHAEL A - Director

    		2022-07-07 17:02:20 -0400 2022-07-05 S 8,700 $5.98 d 102,921 direct yes -6.1341 -6.2767 0.0 1 -9.8431 5

    METZGER MICHAEL A - Director

    		2022-07-07 17:02:20 -0400 2022-07-05 M 91,500 $0.84 a 111,621 direct -6.1341 -6.2767 0.0 1 -9.8431 5

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-05 M 27,000 d 1,173,777 direct

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-05 S 27,000 $6.00 d 22,861 direct yes -1.2676 -10.9859 0.0 1 -10.9859 6

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-05 M 27,000 $0.84 a 49,861 direct -1.2676 -10.9859 0.0 1 -10.9859 6

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-01 M 27,000 $0.84 a 49,861 direct -1.2676 -10.9859 0.0 1 -10.9859 6

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-01 S 27,000 $6.00 d 22,861 direct yes -1.2676 -10.9859 0.0 1 -10.9859 6

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-07-01 M 27,000 d 1,200,777 direct

    CRAIG ADAM R - Director - Officer PRESIDENT AND CEO

    		2022-07-06 17:19:43 -0400 2022-06-30 A 6,183 $2.12 a 22,861 direct -1.2676 -10.9859 0.0 1 -10.9859 6

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-17 16:57:44 -0400 2022-06-17 M 50,000 d 150,000 direct

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-17 16:57:44 -0400 2022-06-17 M 10,000 d 340,000 direct

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-17 16:57:44 -0400 2022-06-17 S 50,000 $6.25 d 7,397 direct yes 2.226 -5.137 19.0068 21.5753 12 -6.3356 7

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-17 16:57:44 -0400 2022-06-17 M 50,000 $3.30 a 57,397 direct 2.226 -5.137 19.0068 21.5753 12 -6.3356 7

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-17 16:57:44 -0400 2022-06-17 S 10,000 $6.00 d 7,397 direct yes 2.226 -5.137 19.0068 21.5753 12 -6.3356 7

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-17 16:57:44 -0400 2022-06-17 M 10,000 $1.00 a 17,397 direct 2.226 -5.137 19.0068 21.5753 12 -6.3356 7

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-16 16:19:11 -0400 2022-06-14 M 10,000 $0.95 a 17,397 direct -4.7308 -7.9935 13.0506 15.8238 13 -10.7667 8

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-16 16:19:11 -0400 2022-06-14 M 10,000 d 490,000 direct

    KIRSKE DAVID - Officer EVP, CHIEF FINANCIAL OFFICER

    		2022-06-16 16:19:11 -0400 2022-06-14 S 10,000 $5.50 d 7,397 direct yes -4.7308 -7.9935 13.0506 15.8238 13 -10.7667 8

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CTI BIOPHARMA CORP CTIC 2022-08-12 22:15:03 UTC 0.9607 1.3593 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 21:45:04 UTC 0.9607 1.3593 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 21:15:04 UTC 0.9607 1.3593 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 20:45:04 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 20:15:05 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 19:45:03 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 19:15:05 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 18:45:03 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 18:15:04 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 17:45:04 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 17:15:05 UTC 0.9602 1.3598 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 16:45:04 UTC 0.9595 1.3605 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 16:15:04 UTC 0.9595 1.3605 3700000
    CTI BIOPHARMA CORP CTIC 2022-08-12 15:45:04 UTC 0.9595 1.3605 3600000
    CTI BIOPHARMA CORP CTIC 2022-08-12 15:15:05 UTC 0.9595 1.3605 3600000
    CTI BIOPHARMA CORP CTIC 2022-08-12 14:45:04 UTC 0.9595 1.3605 3600000
    CTI BIOPHARMA CORP CTIC 2022-08-12 14:15:05 UTC 0.9595 1.3605 3600000
    CTI BIOPHARMA CORP CTIC 2022-08-12 13:45:04 UTC 0.9803 1.3397 3600000
    CTI BIOPHARMA CORP CTIC 2022-08-12 13:15:04 UTC 0.9803 1.3397 3600000
    CTI BIOPHARMA CORP CTIC 2022-08-12 12:45:04 UTC 0.9803 1.3397 3600000

    Current Active Short Positions

    Get more info on our International short position coverage here

    Holder Issuer Net Short Position Position Date Origin

    Short Position History (International Only)

    Holder Net Short Position Position Date Origin
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.62% 2015-04-23 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-04-30 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-05-06 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.58% 2015-05-07 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-05-28 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-05-29 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.47% 2015-06-03 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.5% 2015-06-15 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-07-27 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.59% 2015-07-31 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.6% 2015-08-06 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.58% 2015-08-07 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.62% 2015-10-27 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.51% 2015-10-30 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.23% 2015-11-06 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.19% 2015-11-26 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2015-12-23 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.88% 2015-12-29 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2016-01-12 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.02% 2016-02-11 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.99% 2016-02-25 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.0% 2016-03-18 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2016-03-30 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.22% 2016-05-03 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.19% 2016-05-11 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2016-06-06 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.96% 2016-07-26 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.89% 2016-08-16 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2016-08-29 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.89% 2016-09-09 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.78% 2016-12-05 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.82% 2017-01-05 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.91% 2017-01-09 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.0% 2017-01-11 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2017-01-23 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.08% 2017-01-24 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.1% 2017-01-27 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 1.09% 2017-02-14 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.73% 2017-06-06 Italy
    D. E. Shaw & Co., L.P. CTI BIOPHARMA CORP 0.48% 2017-06-14 Italy
    Jane Street Group, LLC CTI BIOPHARMA CORP 0.56% 2013-12-20 Italy
    Jane Street Group, LLC CTI BIOPHARMA CORP 0.41% 2014-01-02 Italy
    Jane Street Group, LLC CTI BIOPHARMA CORP 0.74% 2014-01-13 Italy
    Jane Street Group, LLC CTI BIOPHARMA CORP 0.35% 2014-01-14 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.07% 2012-11-30 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.97% 2012-12-03 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.35% 2012-12-04 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.42% 2012-12-05 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.37% 2012-12-06 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.54% 2012-12-07 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.37% 2012-12-10 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.15% 2012-12-12 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.05% 2012-12-18 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.95% 2012-12-19 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.19% 2012-12-21 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.24% 2012-12-24 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.3% 2012-12-26 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.29% 2012-12-28 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.38% 2013-01-04 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.0% 2013-01-09 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.0% 2013-01-10 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.94% 2013-01-22 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.01% 2013-01-25 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.99% 2013-01-30 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.01% 2013-02-01 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.99% 2013-02-08 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.0% 2013-02-12 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.23% 2013-02-15 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.18% 2013-02-20 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.25% 2013-02-22 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.17% 2013-02-26 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.07% 2013-03-01 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.98% 2013-03-22 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.04% 2013-03-27 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.96% 2013-03-28 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.85% 2013-04-10 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.28% 2013-04-11 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 1.14% 2013-04-12 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.73% 2013-04-15 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.8% 2013-04-16 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.73% 2013-04-17 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.68% 2013-04-19 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.53% 2013-04-22 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.49% 2013-04-25 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.59% 2013-06-28 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.35% 2013-07-01 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.57% 2013-10-02 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.6% 2013-10-03 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.85% 2013-10-04 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.71% 2013-10-09 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.67% 2013-10-14 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.7% 2013-10-15 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.66% 2013-10-17 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.55% 2013-10-22 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.61% 2013-10-24 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.55% 2013-10-25 Italy
    The Goldman Sachs Group, Inc. CTI BIOPHARMA CORP 0.44% 2013-10-28 Italy
    Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.5% 2015-06-29 Italy
    Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.48% 2015-08-17 Italy
    Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.52% 2017-02-07 Italy
    Two Sigma Advisers, LP CTI BIOPHARMA CORP 0.47% 2017-03-13 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-04-03 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2013-04-17 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2013-05-10 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-05-31 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-07-09 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-08-19 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2013-09-16 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-09-17 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-09-18 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2013-09-20 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2013-09-23 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.46% 2013-09-26 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.62% 2014-02-28 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.71% 2014-03-04 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.57% 2014-03-07 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.44% 2014-03-10 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2014-04-30 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.63% 2014-05-01 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.74% 2014-05-02 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.8% 2014-05-06 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.79% 2014-05-09 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-05-27 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.71% 2014-05-28 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-05-30 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-06-03 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2014-06-17 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-07-24 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-08-26 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-09-18 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2014-10-14 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2014-10-28 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2014-11-07 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-12 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2014-11-19 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-20 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2014-11-21 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-11-24 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2014-12-04 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-12-05 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2014-12-09 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2014-12-26 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.47% 2014-12-31 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.5% 2015-02-02 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2015-02-24 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.58% 2015-02-25 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.61% 2015-03-05 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.78% 2015-03-09 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.66% 2015-03-13 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.74% 2015-03-16 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.83% 2015-03-17 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.75% 2015-03-26 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.69% 2015-03-30 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.55% 2015-04-07 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2015-04-08 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2015-06-19 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.6% 2015-06-26 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.7% 2015-07-10 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.67% 2015-07-13 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.59% 2015-08-27 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2015-10-28 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.51% 2017-02-03 Italy
    Two Sigma Investments, LP CTI BIOPHARMA CORP 0.49% 2017-05-22 Italy

    Elevate your investments